Location: Boston, MA
CIK: 0001595855 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 15, 2023
Total Value: $307M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HROW | HARROW HEALTH INC | 3,795,000 | $54.53M | 17.7% | $6.06 | +188.4% | COM | 415858109 |
| — | ACELYRIN INC | 4,146,138 | $42.17M | 13.7% | $20.90 | — | COM | 00445A100 |
| OCUL | OCULAR THERAPEUTIX INC | 6,468,000 | $20.31M | 6.6% | $4.90 | -16.5% | COM | 67576A100 |
| TGTX | TG THERAPEUTICS INC | 1,890,000 | $15.8M | 5.1% | $13.94 | 0.0% | COM | 88322Q108 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 653,000 | $14.97M | 4.9% | $12.73 | +75.9% | COM | 76243J105 |
| CPRX | CATALYST PHARMACEUTICALS INC | 1,205,000 | $14.09M | 4.6% | $13.38 | 0.0% | COM | 14888U101 |
| KROS | KEROS THERAPEUTICS INC | 360,400 | $11.49M | 3.7% | $47.35 | -21.2% | COM | 492327101 |
| BHVN | BIOHAVEN LTD | 439,000 | $11.42M | 3.7% | $14.12 | +47.2% | COM | G1110E107 |
| CRNX | CRINETICS PHARMACEUTICALS INC | 370,000 | $11M | 3.6% | $20.62 | -0.0% | COM | 22663K107 |
| ETON | ETON PHARMACEUTICALS INC | 2,430,270 | $10.13M | 3.3% | $5.89 | -34.5% | COM | 29772L108 |
| IDYA | IDEAYA BIOSCIENCES INC | 311,500 | $8.404M | 2.7% | $17.38 | +45.9% | COM | 45166A102 |
| — | MORPHOSYS AG | 1,209,380 | $8.127M | 2.6% | $3.87 | — | SPONSORED ADS | 617760202 |
| TELA | TELA BIO INC | 750,000 | $6M | 2.0% | $9.44 | -1.6% | COM | 872381108 |
| EWTX | EDGEWISE THERAPEUTICS INC | 875,405 | $5.016M | 1.6% | $10.13 | -32.9% | COM | 28036F105 |
| KALV | KALVISTA PHARMACEUTICALS INC | 500,000 | $4.815M | 1.6% | $5.36 | +90.7% | COM | 483497103 |
| — | MARINUS PHARMACEUTICALS INC | 584,000 | $4.701M | 1.5% | $3.98 | — | COM NEW | 56854Q200 |
| PCVX | VAXCYTE INC | 90,000 | $4.588M | 1.5% | $38.73 | +27.4% | COM | 92243G108 |
| TARA | PROTARA THERAPEUTICS INC | 2,692,594 | $4.497M | 1.5% | $29.10 | -92.1% | COM STK | 74365U107 |
| URGN | UROGEN PHARMA LTD | 320,000 | $4.483M | 1.5% | $8.22 | +95.4% | COM | M96088105 |
| GERN | GERON CORP | 1,915,000 | $4.06M | 1.3% | $2.85 | -4.6% | COM | 374163103 |
| GOSS | GOSSAMER BIO INC | 4,754,200 | $3.959M | 1.3% | $1.22 | -5.4% | COM | 38341P102 |
| FDMT | 4D MOLECULAR THERAPEUTICS INC | 308,500 | $3.927M | 1.3% | $19.77 | -15.4% | COM | 35104E100 |
| XOMA | XOMA CORP DEL | 274,500 | $3.868M | 1.3% | $11.26 | +39.2% | COM NEW | 98419J206 |
| TRVI | TREVI THERAPEUTICS INC | 1,705,900 | $3.719M | 1.2% | $2.31 | -2.2% | COM | 89532M101 |
| LQDA | LIQUIDIA CORPORATION | 570,700 | $3.618M | 1.2% | $5.52 | +30.4% | COM NEW | 53635D202 |
| LRMR | LARIMAR THERAPEUTICS INC | 848,500 | $3.352M | 1.1% | $7.31 | -48.3% | COM | 517125100 |
| NYXH | NYXOAH S A | 441,896 | $3.115M | 1.0% | $7.81 | +0.3% | SHS | B6S7WD106 |
| — | GOSSAMER BIO INC | 8,000,000 | $3.099M | 1.0% | $0.39 | — | NOTE 5.000% 6/0 | 38341PAA0 |
| — | BIODESIX | 455,573 | $3.038M | 1.0% | $6.67 | — | COM | 09075X108 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 610,000 | $2.776M | 0.9% | $6.78 | -3.8% | COM | 462260100 |
| — | APPLIED THERAPEUTICS | 893,000 | $2.224M | 0.7% | $2.49 | — | COM | 03828A101 |
| — | IGM BIOSCIIENCES INC | 261,000 | $2.179M | 0.7% | $8.56 | — | COM | 449585108 |
| CDXS | CODEXIS INC | 1,118,900 | $2.115M | 0.7% | $3.11 | -24.9% | COM | 192005106 |
| VSTM | VERASTEM INC | 211,400 | $1.719M | 0.6% | $8.32 | +15.4% | COM NEW | 92337C203 |
| PGEN | PRECIGEN INC | 928,500 | $1.318M | 0.4% | $1.42 | 0.0% | COM | 74017N105 |
| — | TRACON PHARMACEUTICALS INC | 4,764,508 | $848K | 0.3% | $4.42 | — | COM NEW | 89237H209 |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 390,000 | $725K | 0.2% | $2.29 | 0.0% | COM | 98422E103 |
| — | FORTRESS BIOTECH INC | 2,000,000 | $581K | 0.2% | $1.66 | — | COM | 34960Q109 |
| — | KEZAR LIFE SCIENCES INC | 425,000 | $506K | 0.2% | $1.64 | — | COM | 49372L100 |
| RLMD | RELMADA THERAPEUTICS INC | 30,000 | $90,000 | 0.0% | $2.97 | 0.0% | COM | 75955J402 |